Other
Heavy Drinker
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Heavy Drinker is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
10
clinical trials
Completed5 · 50%
Terminated3 · 30%
Recruiting2 · 20%
Clinical Trials
Trial Activity
10 trials
Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers
Recruiting·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 1·NCT04781322·100 enrolled
Levetiracetam XR in Very Heavy Drinkers
Completed·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 2·NCT00970814·130 enrolled
Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers
Completed·—·Phase 1·NCT03271528·66 enrolled
Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers
Completed·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 2·NCT01779024·17 enrolled
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Terminated·—·Phase 1·NCT03645408·8 enrolled
Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
Terminated·—·Phase 1·NCT04596267·9 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)